NCT06022263 - STA363 in the Treatment of Lumbar Disc Herniation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 25, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

August 31, 2024

Conditions

Lumbar Disc Herniation

Interventions

DRUG

Lactic Acid

180 mg of STA363 will be slowly injected into a symptom-generating herniated lumbar disc

DRUG

Placebo

1.5 mL of Omnipaque in water for injection will be slowly injected into a symptom-generating herniated lumbar disc

Trial Locations (1)

RECRUITING

Samodzielny Publiczny Szpital Kliniczny nr 4, Klinika Ortopedii i Rehabilitacji, Lublin